These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3591549)

  • 1. Apolipoproteins induced by an antimitotic agent.
    Dousset N; Loudet AM; Lespine A; Carton M; Douste-Blazy L; Chap H
    Adv Exp Med Biol; 1987; 210():201-8. PubMed ID: 3591549
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of an antimitotic agent (cyclophosphamide) on plasma lipoproteins.
    Loudet AM; Dousset N; Carton M; Douste-Blazy L
    Biochem Pharmacol; 1984 Oct; 33(19):2961-5. PubMed ID: 6487348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase.
    Breckenridge WC; Little JA; Alaupovic P; Wang CS; Kuksis A; Kakis G; Lindgren F; Gardiner G
    Atherosclerosis; 1982 Nov; 45(2):161-79. PubMed ID: 6961921
    [No Abstract]   [Full Text] [Related]  

  • 4. [In vivo catabolism of lipid and protein moieties of blood very low and low density lipoproteins in rabbits].
    Klimov AI; Andreeva LI; Popov AV
    Vopr Med Khim; 1982; 28(1):131-5. PubMed ID: 7064379
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat.
    Groener JE; van Gent T; van Tol A
    Biochim Biophys Acta; 1989 Mar; 1002(1):93-100. PubMed ID: 2493808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an antimitotic agent (cyclophosphamide) on post-heparin plasma lipoprotein lipase activity in rabbit.
    Loudet AM; Dousset N; Carton M; Douste-Blazy L
    Biochem Pharmacol; 1985 Oct; 34(19):3597-9. PubMed ID: 4052100
    [No Abstract]   [Full Text] [Related]  

  • 7. Relative rates of incorporation of esterified cholesterol into human very low density lipoproteins and low density lipoproteins. In vitro studies of two separate pathways.
    Barter PJ; Hopkins GJ
    Biochim Biophys Acta; 1983 Mar; 751(1):33-40. PubMed ID: 6830830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of a human serum cholesteryl ester transfer protein.
    Chajek T; Fielding CJ
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3445-9. PubMed ID: 210460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolemia.
    Bagdade JD; Ritter MC; Subbaiah PV
    J Clin Invest; 1991 Apr; 87(4):1259-65. PubMed ID: 2010540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turnover and aortic uptake of very low density lipoproteins (VLDL) from hypercholesteremic rabbits: effect of metformin.
    Sirtori CR; Innocenti L; Grigolato PG; Rodriguez J
    Adv Exp Med Biol; 1977; 82():268-71. PubMed ID: 200095
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of VLDL and LDL subclasses.
    Griffin BA; Packard CJ
    Curr Opin Lipidol; 1994 Jun; 5(3):200-6. PubMed ID: 7952914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfers and exchanges of esterified cholesterol between plasma lipoproteins.
    Barter PJ; Hopkins GJ; Calvert GD
    Biochem J; 1982 Oct; 208(1):1-7. PubMed ID: 6760853
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cholesteryl ester transfer protein (CETP)].
    Kinoshita M; Teramoto T
    Nihon Rinsho; 1999 Sep; 57 Suppl():83-6. PubMed ID: 10543055
    [No Abstract]   [Full Text] [Related]  

  • 14. The origin and fate of LDL.
    Stein Y; Stein O
    Adv Exp Med Biol; 1977; 82():413-20. PubMed ID: 200101
    [No Abstract]   [Full Text] [Related]  

  • 15. Isolation and specificity of a Mr 74,000 cholesteryl ester transfer protein from human plasma.
    Jarnagin AS; Kohr W; Fielding C
    Proc Natl Acad Sci U S A; 1987 Apr; 84(7):1854-7. PubMed ID: 3470761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects.
    Kashyap ML; Srivastava LS; Chen CY; Perisutti CG; Campbell M; Lutmer RF; Glueck CJ
    J Clin Invest; 1977 Jul; 60(1):171-80. PubMed ID: 194919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic determinants of plasma high-density lipoprotein concentration in humans.
    Miller NE
    Adv Exp Med Biol; 1987; 210():111-5. PubMed ID: 3591542
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in apolipoproteins and properties of rabbit very low density lipoproteins on induction of cholesteremia.
    Shore VG; Shore B; Hart RG
    Biochemistry; 1974 Apr; 13(8):1579-85. PubMed ID: 4364705
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of the plasma cholesteryl ester transfer by stachybotramide.
    Takahashi F; Hasumi K; Endo A
    Biochim Biophys Acta; 1995 Aug; 1258(1):70-4. PubMed ID: 7654783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triacylglycerol increase in plasma very low density lipoproteins in cyclophosphamide-treated rabbit: relationship with cholesteryl ester transfer activity.
    Loudet AM; Dousset N; Perret B; Ierides M; Carton M; Douste-Blazy L
    Biochim Biophys Acta; 1985 Oct; 836(3):376-84. PubMed ID: 4041478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.